INSP Inspire Medical Systems Inc.
Health Care, filed as INSPIRE MED SYS INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab
In 2026 Q2 Ron Baron sold out of Inspire Medical Systems.
Who owns this now
Largest portfolio weights among holders, up to 0.2% (Nathan Fischel, Dafna Capital Management). Not free-float ownership.
Who owns INSP
Sorted by value, long equity only, as of 2026 Q2. Exits show their last held size.
| History | |||||
|---|---|---|---|---|---|
| Nathan Fischel, Dafna Capital Management | Hold | 18,200 | $812K | History | |
| Palo Alto Investors | Hold | 8,772 | $391K | History | |
| Ron Baron, Bamco Inc. (Baron Capital) exited 2026 Q2 Last 2026 Q1 | Exit −0.05% | 298,470 | $15M | History |
Insider trades
Open-market buys and sales by INSP's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $202K sold by 2 insiders outside a trading plan
- $464K sold by 2 insiders under 10b5-1 plans
-
Jason P Kelly See RemarksSale$57K 963 shares at $59.55 4.8% of stakeTraded Aug 7 Filed Aug 11
-
John Rondoni See RemarksSale$114K 2,641 shares at $43.28 8.9% of stakeTraded May 15 Filed May 19
-
John Rondoni See RemarksSale$30K 700 shares at $43.01 2.3% of stakeTraded May 14 Filed May 15
-
Shawn mcCormick DirectorPlanned sale$32K 696 shares at $45.31 2.5% of stakeTraded May 8 Filed May 11
-
John Rondoni See RemarksPlanned sale$11K 109 shares at $100.00 0.8% of stakeTraded Jan 9 Filed Jan 12
-
Shawn mcCormick DirectorPlanned sale$167K 1,200 shares at $139.00 4.6% of stakeTraded Dec 2, 2025 Filed Dec 4, 2025
-
Shawn mcCormick DirectorPlanned sale$255K 2,000 shares at $127.48 7.1% of stakeTraded Nov 28, 2025 Filed Dec 1, 2025
-
Myriam Curet DirectorBuy$804 5 shares at $160.72 +0.1% to stakeTraded Mar 20, 2025–Apr 7, 2025 Filed Nov 24, 2025
-
Myriam Curet DirectorSale$616 6 shares at $102.59 0.2% of stakeTraded May 8, 2025–Aug 8, 2025 Filed Nov 24, 2025
Also filed in the last 12 months, not counted as buying or selling: 38 stock grants and 18 share withholdings for taxes.
SEC filings
Recent issuer filings from EDGAR, 17 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 2.02,7.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 5.02 | Filing Doc | |
| 8-K | 5.02,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 5.02,5.03,5.07,9.01 | Filing Doc | |
| 8-K | 2.02,7.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc |
No filings match this filter.
Financials
US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.
Income statement
Balance sheet
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total current assets | $593.74M | $630.81M | $583.65M |
| Total non-current assets * | $83.07M | $177.58M | $323.66M |
| Total assets | $676.81M | $808.38M | $907.32M |
| Total current liabilities | $78.1M | $88.5M | $96.06M |
| Total non-current liabilities * | $26.19M | $30.19M | $30.1M |
| Total equity | $572.51M | $689.7M | $781.16M |
Ownership over time
13Fs that reported it each quarter. Click a bar for that quarter’s holders.